ArticleSurgery today2026
Can machine learning predict vessels that encapsulates tumor cluster ptterns and histological differentiation in solitary small (< 5 cm) hepatocellular carcinoma?
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. Machine learning (ML) may enable the noninvasive prediction of histopathological features using clinical and imaging data. This study evaluated the utility of ML in predicting vessels that encapsulate tumor clusters (VETC) and tumor differentiation in HCC. We retrospectively analyzed 232 patients who underwent hepatic resection for solitary HCC (≤ 5 cm). Histological assessment was used to determine the VETC status and tumor differentiation. Contrast-enhanced CT images were processed using BiomedCLIP to extract 512-dimensional image feature vectors, which were combined with clinical data and analyzed using a support vector machine classifier. The model performance was evaluated using five-fold cross-validation with precision, recall, and F1-score. VETC-positive tumors were significantly associated with a poor survival. Models using clinical data alone demonstrated limited predictive performance (F1 = 0.469 for VETC; F1 = 0.473 for differentiation). The incorporation of image features modestly improved VETC prediction (F1 = 0.599) but did not enhance the prediction of tumor differentiation. Image-based models did not outperform the clinical models. VETC is a histopathological marker associated with a poor prognosis in HCC. While ML models showed limited predictive accuracy, further optimization of imaging analysis and data integration may improve noninvasive histological prediction.
Indexed as
Identifiers
42189245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.